Related Experiment Video
Updated: Jun 19, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor
Nico Buettner1, Carola Vogt, Luis Martínez-Sobrido
1Abteilung Virologie, Universität Freiburg, D-79008 Freiburg, Germany.
Abstract:
The tick-transmitted orthomyxovirus Thogoto virus (THOV) encodes the ML protein acting as a viral suppressor of the host interferon (IFN) system. Here, we describe that type I IFN is strongly induced in primary mouse embryo fibroblasts as well as plasmacytoid dendritic cells upon infection with a THOV mutant lacking the ML gene. However, wild-type THOV encoding ML suppresses induction of IFN by preventing the activation of members of the IFN regulatory factor (IRF) family. We found that reporter gene expression dependent on IRF3 and IRF7 was strongly inhibited by ML. Further experiments revealed that ML interacts with IRF7 and prevents dimerization of the transcription factor and its association with the coactivator TRAF6. Interestingly, another IRF7 activation step, nuclear translocation, is not affected by ML. Our data elucidate ML protein as a virulence factor with an IRF-specific IFN-antagonistic spectrum.
Insights
Thogoto virus (THOV) ML protein suppresses host interferon (IFN) immunity. ML inhibits IFN induction by blocking interferon regulatory factor (IRF) activation, revealing its role as a viral virulence factor.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Thogoto virus (THOV) is a tick-borne orthomyxovirus.
- THOV possesses a viral suppressor of the RNA virus-sensing interferon (IFN) system, the ML protein.
- Understanding viral immune evasion mechanisms is crucial for antiviral strategies.
Purpose of the Study:
- To investigate the role of the THOV ML protein in suppressing the host type I IFN response.
- To elucidate the molecular mechanism by which ML antagonizes IFN induction.
- To identify the specific host factors targeted by ML.
Main Methods:
- Infection of primary mouse embryo fibroblasts and plasmacytoid dendritic cells with wild-type and ML-deficient THOV.
- Reporter gene assays to measure IFN regulatory factor (IRF) activation (IRF3 and IRF7).
- Co-immunoprecipitation assays to study protein-protein interactions between ML and IRF7, and TRAF6.
- Analysis of IRF7 nuclear translocation.
Main Results:
- THOV lacking ML strongly induces type I IFN, while wild-type THOV suppresses it.
- ML inhibits reporter gene expression dependent on IRF3 and IRF7.
- ML directly interacts with IRF7, preventing its dimerization and association with TRAF6.
- ML does not affect the nuclear translocation of IRF7.
Conclusions:
- The THOV ML protein is a key virulence factor that antagonizes the host type I IFN response.
- ML specifically targets IRF family members, inhibiting their activation upstream of nuclear translocation.
- ML acts by preventing IRF7 dimerization and subsequent TRAF6 association, thereby suppressing IFN induction.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

